glp 1 agonists for obesity used weight loss GLP-1 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight GLP-1 Genetics: How Genes Affect
Description
Shiraishi D, Fujiwara Y, Komohara Y, Mizuta H, Takeya M
Endogenous glucagon-like peptide-1 suppresses high-fat food intake by reducing synaptic drive onto mesolimbic dopamine neurons
Neither drug manufacturer commented on the lawsuit specifically, but they emphasized the differences between their products
evaluated the effect of semaglutide in a 52-week randomized, double-blinded, placebo-controlled trial involving adults with increased fracture risk
They expect Novo Nordisk's oral semaglutide to have a 21% share or around $4 billion of that segment
